HFA Premium Access

Broadening the evidence base for rivaroxaban in heart failure.


Congress Presentation

About the speaker

Professor Barry Greenberg

University of California San Diego, San Diego (United States of America)
6 presentations
0 follower

5 more presentations in this session

Introduction & remarks.

Speaker: Professor N. Danchin (Paris, FR)


Expanding the evidence for rivaroxaban in Atrial Fibrillation (AF) patients with comorbidites including Heart Failure (HF): from Randomized Controlled Trials (RCT) to Real World Evidence (RWE).

Speaker: Professor M. Cowie (Cambridge, GB)


Options in thrombosis prevention and vascular health – What’s on the horizon?

Speaker: Professor K. Fox (Edinburgh, GB)


Exploring new frontiers: is it time for a comorbidity-based approach in heart failure?

Speaker: Doctor R. Mentz (Durham, US)


Q&A and closing remarks.

Speaker: Professor M. Cowie (Cambridge, GB)


Access the full session

Management of co-morbidities in heart failure - Exploring new frontiers

Speakers: Professor B. Greenberg, Professor N. Danchin, Professor M. Cowie, Professor K. Fox, Doctor R. Mentz...

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb